PERSPECTA

News from every angle

Back to headlines

Moderna Prices Upsized $2.6 Billion Convertible Senior Notes Offering

The pharmaceutical company successfully priced a significantly increased debt issuance aimed at strengthening its balance sheet and funding future research and development initiatives.

28 Aug, 11:09 — 28 Aug, 11:09
PostShare

Sources

Showing 1 of 1 sources